Viral hepatocarcinogenesis
暂无分享,去创建一个
[1] A. Lonardo,et al. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. , 2004, Gastroenterology.
[2] F. Su,et al. Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins , 1996, Journal of virology.
[3] D. Samuel,et al. Liver Cancer-Derived Hepatitis C Virus Core Proteins Shift TGF-Beta Responses from Tumor Suppression to Epithelial-Mesenchymal Transition , 2009, PloS one.
[4] A. Hevener,et al. IKK-beta links inflammation to obesity-induced insulin resistance. , 2005, Nature medicine.
[5] K. Flanders,et al. Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis. , 1996, The Journal of clinical investigation.
[6] Charles M. Rice,et al. Unravelling hepatitis C virus replication from genome to function , 2005, Nature.
[7] K. Koike. Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection , 2009, Journal of Gastroenterology.
[8] J. Jacob,et al. Hepatocellular carcinoma in the woodchuck model of hepatitis B virus infection. , 2004, Gastroenterology.
[9] D. Häussinger,et al. CD133+ hepatic stellate cells are progenitor cells. , 2007, Biochemical and biophysical research communications.
[10] S. Schaefer. Hepatitis B virus: significance of genotypes , 2005, Journal of viral hepatitis.
[11] X. Gu,et al. An intronic polymorphism in the corticotropin-releasing hormone receptor 2 gene increases susceptibility to HBV-related hepatocellular carcinoma in Chinese population , 2009, Human Genetics.
[12] Jacques Ferlay,et al. Estimates of the worldwide incidence of 25 major cancers in 1990 , 1999, International journal of cancer.
[13] A. Franchitto,et al. New insights into liver stem cells. , 2009, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[14] A. Siddiqui,et al. Hepatitis C Virus Subgenomic Replicons Induce Endoplasmic Reticulum Stress Activating an Intracellular Signaling Pathway , 2002, Journal of Virology.
[15] I. Su,et al. Enhanced expression of vascular endothelial growth factor‐A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis , 2009, Hepatology.
[16] Chien-Jen Chen,et al. Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma. , 2003, Journal of the National Cancer Institute.
[17] R. Ray,et al. Expression of hepatitis C virus non‐structural 5A protein in the liver of transgenic mice , 2003, FEBS letters.
[18] R. Bartenschlager,et al. Replication of hepatitis C virus. , 2000, The Journal of general virology.
[19] Chien-Jen Chen,et al. Hepatitis B virus DNA levels and outcomes in chronic hepatitis B , 2009, Hepatology.
[20] H. Kwun,et al. Dual effects of hepatitis C virus Core protein on the transcription of cyclin‐dependent kinase inhibitor p21 gene , 2003, Journal of viral hepatitis.
[21] A. Kurimasa,et al. Suppressive effects of retinoids on iron-induced oxidative stress in the liver. , 2009, Gastroenterology.
[22] T. Furuya,et al. Chromosomal imbalances detected by comparative genomic hybridization are associated with outcome of patients with hepatocellular carcinoma , 2002, Cancer.
[23] Derek Y. Chiang,et al. Genomics and signaling pathways in hepatocellular carcinoma. , 2007, Seminars in liver disease.
[24] H. Kwun,et al. p53-dependent transcriptional repression of p21(waf1) by hepatitis C virus NS3. , 2001, The Journal of general virology.
[25] F. Chisari. Unscrambling hepatitis C virus–host interactions , 2005, Nature.
[26] K. Koike,et al. Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator‐activated receptor α in transgenic mice: Implications for HCV‐associated hepatocarcinogenesis , 2008, International journal of cancer.
[27] P Boffetta,et al. A meta‐analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma , 1998, International journal of cancer.
[28] R. Palmiter,et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice , 1989, Cell.
[29] Chien-Jen Chen,et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. , 2005, Journal of the National Cancer Institute.
[30] Mohamed Hassan,et al. Hepatitis C virus core protein triggers hepatic angiogenesis by a mechanism including multiple pathways , 2009, Hepatology.
[31] Ding‐Shinn Chen,et al. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. , 2000, Gastroenterology.
[32] I. Su,et al. Hepatitis B virus pre‐S mutants, endoplasmic reticulum stress and hepatocarcinogenesis , 2006, Cancer science.
[33] R. Chung,et al. Treatment failure in hepatitis C: mechanisms of non-response. , 2009, Journal of hepatology.
[34] Y. Jeng,et al. Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma , 2007, International journal of cancer.
[35] Shinn-Jang Hwang,et al. HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis , 2002, Oncogene.
[36] S. Thorgeirsson,et al. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China , 2002, Hepatology.
[37] Ding‐Shinn Chen,et al. INAUGURAL ARTICLE by a Recently Elected Academy Member:Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level , 2007 .
[38] T. Niki,et al. Class VI intermediate filament protein nestin is induced during activation of rat hepatic stellate cells , 1999, Hepatology.
[39] S. Friedman,et al. Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors. , 1989, The Journal of clinical investigation.
[40] V. Mazzaferro,et al. Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma , 2007, Hepatology.
[41] M. Czaja,et al. Cell signaling in oxidative stress-induced liver injury. , 2007, Seminars in liver disease.
[42] M. Rattray,et al. A tumor progression model for hepatocellular carcinoma: bioinformatic analysis of genomic data. , 2006, Gastroenterology.
[43] K. Matsuzaki. Modulation of TGF-beta signaling during progression of chronic liver diseases. , 2009, Frontiers in bioscience.
[44] Y. Kwong,et al. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis. , 2007, Gastroenterology.
[45] K. Meyer,et al. Transcriptional Repression of p53 Promoter by Hepatitis C Virus Core Protein* , 1997, The Journal of Biological Chemistry.
[46] M. Kew. Hepatic iron overload and hepatocellular carcinoma. , 2009, Cancer letters.
[47] J. Bruix,et al. Molecular targeted therapies in hepatocellular carcinoma , 2008, Hepatology.
[48] I. Gareen,et al. National Institutes of Health consensus development conference statement: Management of hepatitis B , 2009, Hepatology.
[49] Christine Pourcel,et al. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma , 1980, Nature.
[50] S. Lemon,et al. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein. , 2006, Gastroenterology.
[51] N. Iizuka,et al. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. , 2002, Cancer research.
[52] K. Horimoto,et al. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma , 2009, Hepatology.
[53] O. Hino,et al. Hepatitis C Virus Core Protein Interacts with 14-3-3 Protein and Activates the Kinase Raf-1 , 2000, Journal of Virology.
[54] M. Gambardella,et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity , 2001, Hepatology.
[55] P. Hofschneider,et al. Integrated hepatitis B virus X and 3' truncated preS/S sequences derived from human hepatomas encode functionally active transactivators. , 1994, Oncogene.
[56] H. Sumimoto,et al. Regulation of novel superoxide-producing NAD(P)H oxidases. , 2006, Antioxidants & redox signaling.
[57] A. Clouston,et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis , 1999, Hepatology.
[58] R. Bartenschlager,et al. Hepatitis C virus core triggers apoptosis in liver cells by inducing ER stress and ER calcium depletion , 2005, Oncogene.
[59] R. Ray,et al. Hepatitis C Virus Core Protein Augments Androgen Receptor-Mediated Signaling , 2008, Journal of Virology.
[60] C. Harris,et al. Hepatitis B virus X protein inhibits nucleotide excision repair , 1999, International journal of cancer.
[61] V. Mazzaferro,et al. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. , 2006, Gastroenterology.
[62] H. Herbst,et al. Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. , 1996, The American journal of pathology.
[63] Ding‐Shinn Chen,et al. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. , 2003, Gastroenterology.
[64] S. Murakami,et al. Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. , 1999, Journal of hepatology.
[65] J. Chang,et al. HCV core protein modulates Rb pathway through pRb down-regulation and E2F-1 up-regulation. , 2001, Biochimica et biophysica acta.
[66] G. Yamada,et al. Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C. , 2004, Antioxidants & redox signaling.
[67] R. Ray,et al. Hepatitis C Virus NS5A Physically Associates with p53 and Regulates p21/waf1 Gene Expression in a p53-Dependent Manner , 2001, Journal of Virology.
[68] H. El‐Serag,et al. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.
[69] G. Fontemaggi,et al. Physical and functional interaction between HCV core protein and the different p73 isoforms , 2003, Oncogene.
[70] T. Takegami,et al. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells , 1995, Journal of virology.
[71] S. Friedman,et al. Experimental models of hepatocellular carcinoma. , 2008, Journal of hepatology.
[72] P. Arora,et al. Hepatitis C virus core protein downregulates E-cadherin expression via activation of DNA methyltransferase 1 and 3b. , 2008, Cancer letters.
[73] In-Kyung Kim,et al. Activation of calcium signaling by hepatitis B virus-X protein in liver cells , 2003, Experimental & Molecular Medicine.
[74] W. Gerlich,et al. Hypermodification and immune escape of an internally deleted middle-envelope (M) protein of frequent and predominant hepatitis B virus variants. , 2002, Virology.
[75] Mohamed Hassan,et al. Activation of c-Jun NH2-terminal kinase (JNK) signaling pathway is essential for the stimulation of hepatitis C virus (HCV) non-structural protein 3 (NS3)-mediated cell growth. , 2005, Virology.
[76] Hiroyoshi Taniguchi,et al. Hepatitis C virus core protein upregulates transforming growth factor-beta 1 transcription. , 2004, Journal of medical virology.
[77] C. J. Chen,et al. Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic hepatitis virus infection. , 1999, American journal of epidemiology.
[78] K Koike,et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. , 1997, The Journal of general virology.
[79] H. Ren,et al. Hepatitis C virus E2 protein promotes human hepatoma cell proliferation through the MAPK/ERK signaling pathway via cellular receptors. , 2005, Experimental cell research.
[80] S. Weinman,et al. Causes and consequences of mitochondrial reactive oxygen species generation in hepatitis C , 2006, Journal of gastroenterology and hepatology.
[81] H. M. Reis,et al. Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease. , 2009, Cancer letters.
[82] T. Kodama,et al. Subcellular localization of HCV core protein regulates its ability for p53 activation and p21 suppression. , 2002, Biochemical and biophysical research communications.
[83] K. Eguchi,et al. Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection , 2003, Cancer.
[84] J. Woodgett,et al. X Protein of Hepatitis B Virus Inhibits Fas-mediated Apoptosis and Is Associated with Up-regulation of the SAPK/JNK Pathway* , 2001, The Journal of Biological Chemistry.
[85] Yoon-Koo Kang,et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. , 2009, The Lancet. Oncology.
[86] L. Roberts,et al. The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma. , 2005, Journal of hepatology.
[87] S. Thorgeirsson,et al. Expression of stem cell factor and its receptor, c-kit, during liver regeneration from putative stem cells in adult rat. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[88] S. Nuti,et al. Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein , 2002, The Journal of experimental medicine.
[89] E. Yu,et al. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. , 2007, Gastroenterology.
[90] L. Wang,et al. Calcium signaling by HBx protein in hepatitis B virus DNA replication. , 2001, Science.
[91] D. Häussinger,et al. Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-Off cell line. , 2002, Virology.
[92] C. Boland,et al. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma , 2008, Hepatology.
[93] J. Pekow,et al. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C‐related cirrhosis , 2007, Cancer.
[94] Soo-Ho Choi,et al. Modulation of the Transforming Growth Factor-β Signal Transduction Pathway by Hepatitis C Virus Nonstructural 5A Protein* , 2006, Journal of Biological Chemistry.
[95] S. Kaneko,et al. Molecular functions and biological roles of hepatitis B virus x protein , 2006, Cancer science.
[96] Ding‐Shinn Chen,et al. Therapeutic implications of hepatitis B virus genotypes , 2005, Liver international : official journal of the International Association for the Study of the Liver.
[97] Christopher J. Parsons,et al. Molecular mechanisms of hepatic fibrogenesis , 2007, Journal of gastroenterology and hepatology.
[98] M. Lai,et al. Hepatitis C Virus Triggers Mitochondrial Permeability Transition with Production of Reactive Oxygen Species, Leading to DNA Damage and STAT3 Activation , 2006, Journal of Virology.
[99] K. Koike,et al. High‐level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice , 1994, Hepatology.
[100] A. Kurimasa,et al. Retinoic acid receptor α dominant negative form causes steatohepatitis and liver tumors in transgenic mice , 2004, Hepatology.
[101] J. Wands,et al. Hepatitis C virus core protein stimulates hepatocyte growth: Correlation with upregulation of wnt‐1 expression , 2005, Hepatology.
[102] Y. Shin,et al. Liver X receptor mediates hepatitis B virus X protein–induced lipogenesis in hepatitis B virus–associated hepatocellular carcinoma , 2009, Hepatology.
[103] Kook Hwan Kim,et al. Hepatitis B virus X protein induces lipogenic transcription factor SREBP1 and fatty acid synthase through the activation of nuclear receptor LXRalpha. , 2008, The Biochemical journal.
[104] S. Shoelson,et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. , 2005, Nature medicine.
[105] I. Ng,et al. Molecular Pathogenesis of Hepatocellular Carcinoma , 2016, Liver Cancer.
[106] T. Liang,et al. Mouse models for the study of HCV infection and virus–host interactions , 2008, Journal of Hepatology.
[107] M. Honda,et al. Different signaling pathways in the livers of patients with chronic hepatitis B or chronic hepatitis C , 2006, Hepatology.
[108] B. Bacon,et al. Effects of iron loading on pathogenicity in hepatitis C virus–infected chimpanzees , 1999, Hepatology.
[109] N. Savaraj,et al. Roles of reactive oxygen species in hepatocarcinogenesis and drug resistance gene expression in liver cancers , 2006, Molecular carcinogenesis.
[110] J. Sicklick,et al. Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells. , 2008, Journal of hepatology.
[111] J. Wands,et al. Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma , 2006, Hepatology.
[112] R. Schneider,et al. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[113] Chien-Jen Chen,et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. , 2006, Gastroenterology.
[114] J. Vinel,et al. Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase. , 2001, The Journal of biological chemistry.
[115] D. Shafritz,et al. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens. , 1981, The New England journal of medicine.
[116] K. Koike,et al. Multiple integration site of hepatitis B virus DNA in hepatocellular carcinoma and chronic active hepatitis tissues from children , 1987, Journal of virology.
[117] Ze-Guang Han,et al. Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A. , 2009, Journal of hepatology.
[118] M. Manns,et al. Telomeres and telomerase: A dual role in hepatocarcinogenesis , 2004, Hepatology.
[119] N. Holbrook,et al. Cellular response to oxidative stress: Signaling for suicide and survival * , 2002, Journal of cellular physiology.
[120] M. Lai,et al. Hepatitis C Virus Core Protein Interacts with Heterogeneous Nuclear Ribonucleoprotein K* , 1998, The Journal of Biological Chemistry.
[121] H. El‐Serag. Hepatocellular carcinoma and hepatitis C in the United States , 2002, Hepatology.
[122] P. Schirmacher,et al. Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade – results of an explorative CGH meta-analysis , 2005, British Journal of Cancer.
[123] Jacques Ferlay,et al. Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.
[124] C. Sabin,et al. HBV A1762T, G1764A Mutations Are a Valuable Biomarker for Identifying a Subset of Male HBsAg Carriers at Extremely High Risk of Hepatocellular Carcinoma: A Prospective Study , 2008, The American Journal of Gastroenterology.
[125] T. Braciale,et al. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. , 2000, The Journal of clinical investigation.
[126] M. Feitelson,et al. Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. , 2007, Cancer letters.
[127] A. Lok,et al. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. , 2002, Gastroenterology.
[128] E. Schmidt,et al. Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis , 2005, Hepatology.
[129] Y. Liaw,et al. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma , 2007, Gut.
[130] B. Bell,et al. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. , 2006, Journal of hepatology.
[131] Yong Poovorawan,et al. Interleukin-1beta gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection. , 2006, World journal of gastroenterology.
[132] K. Okita,et al. Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: Their relationship to clinicopathological features , 1999, Hepatology.
[133] J. Dubuisson,et al. Positive effect of the hepatitis C virus nonstructural 5A protein on viral multiplication , 2004, Archives of Virology.
[134] K. Koike,et al. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)‐β signaling from tumor suppression to oncogenesis in early chronic hepatitis B , 2009, Hepatology.
[135] S. Paggi,et al. Sorafenib in Advanced Hepatocellular Carcinoma , 2008 .
[136] John D. Groopman,et al. Prospective Evaluation of Hepatitis B 1762T/1764A Mutations on Hepatocellular Carcinoma Development in Shanghai, China , 2009, Cancer Epidemiology Biomarkers & Prevention.
[137] T. Tsunoda,et al. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. , 2001, Cancer research.
[138] R. Fisher,et al. Genes Involved in Viral Carcinogenesis and Tumor Initiation in Hepatitis C Virus-Induced Hepatocellular Carcinoma , 2009, Molecular medicine.
[139] K. Jeang,et al. Hepatitis C virus core protein‐induced loss of LZIP function correlates with cellular transformation , 2000, The EMBO journal.
[140] S. Sarin,et al. Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent , 2002, Journal of gastroenterology and hepatology.
[141] Alexander Bürkle,et al. Increase in de novo HBV DNA integrations in response to oxidative DNA damage or inhibition of poly(ADP‐ribosyl)ation , 2002, Hepatology.
[142] K. Koike,et al. Interaction of hepatitis C virus core protein with retinoid X receptor α modulates its transcriptional activity , 2002, Hepatology.
[143] M. Ostrowski,et al. Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors. , 2008, Gastroenterology.
[144] Chien-Jen Chen,et al. Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men. , 2008, Carcinogenesis.
[145] T. Roskams,et al. HBx or HCV core gene expression in HepG2 human liver cells results in a survival benefit against oxidative stress with possible implications for HCC development. , 2007, Chemico-biological interactions.
[146] S. Hirohashi,et al. Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: identification of genetic indicators to predict patient outcome. , 2005, Journal of hepatology.
[147] G. Jay,et al. HBx gene of hepatitis B virus induces liver cancer in transgenic mice , 1991, Nature.
[148] M. Anzola. Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis , 2004, Journal of viral hepatitis.
[149] T. Okanoue,et al. Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas , 2005, Gut.
[150] S. Kojima,et al. Retinoids in liver fibrosis and cancer. , 2002, Frontiers in bioscience : a journal and virtual library.
[151] Guan-Tarn Huang,et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. , 2006, JAMA.
[152] S. Satoh,et al. Comprehensive allelotype study of hepatocellular carcinoma: Potential differences in pathways to hepatocellular carcinoma between hepatitis B virus–positive and –negative tumors , 2000, Hepatology.
[153] Peter Schirmacher,et al. MicroRNA gene expression profile of hepatitis C virus–associated hepatocellular carcinoma , 2007, Hepatology.
[154] C. W. Kim,et al. HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-β1 , 2005, Experimental & Molecular Medicine.
[155] M. Mizokami,et al. Hepatitis B Virus Genotypes and Hepatocellular Carcinoma in Japan , 2003, Intervirology.
[156] H. Fukuda,et al. Metal Contents in the Liver of Patients with Chronic Liver Disease Caused by Hepatitis C Virus , 2003, Oncology.
[157] P. Hofschneider,et al. Hepatoma-derived integrated HBV DNA causes multi-stage transformation in vitro. , 1996, Oncogene.
[158] K. Koike. Pathogenesis of HCV‐associated HCC: Dual‐pass carcinogenesis through activation of oxidative stress and intracellular signaling , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.
[159] M. Sheu,et al. Hepatitis C virus NS5A as a potential viral Bcl‐2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma , 2003, International journal of cancer.
[160] N. Kato,et al. NS3 protein of Hepatitis C virus associates with the tumour suppressor p53 and inhibits its function in an NS3 sequence-dependent manner. , 2006, The Journal of general virology.
[161] Andrew Macdonald,et al. Hepatitis C Virus NS5A-Mediated Activation of Phosphoinositide 3-Kinase Results in Stabilization of Cellular β-Catenin and Stimulation of β-Catenin-Responsive Transcription , 2005, Journal of Virology.
[162] C. J. Chen,et al. Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. , 2001, Journal of the National Cancer Institute.
[163] Giuseppe Vasapollo,et al. Autophagy inhibition enhances anthocyanin-induced apoptosis in hepatocellular carcinoma , 2008, Molecular Cancer Therapeutics.
[164] Victor V. Keasler,et al. Enhancement of Hepatitis B Virus Replication by the Regulatory X Protein In Vitro and In Vivo , 2006, Journal of Virology.
[165] A. Siddiqui,et al. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-κB , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[166] Bao-zong Li,et al. Hepatitis B virus X protein (HBx) activates ATF6 and IRE1-XBP1 pathways of unfolded protein response. , 2007, Virus research.
[167] O. Hino,et al. Hepatitis C virus core protein activates the MAPK/ERK cascade synergistically with tumor promoter TPA, but not with epidermal growth factor or transforming growth factor alpha. , 2000, Hepatology.
[168] A. Fukushima,et al. Clinical Significance of Evaluation of Serum Zinc Concentrations in C-Viral Chronic Liver Disease , 2006, Digestive Diseases and Sciences.
[169] T. Wakita,et al. Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response , 2008, Hepatology.
[170] G. Gwak,et al. Wnt signaling enhances the activation and survival of human hepatic stellate cells , 2007, FEBS Letters.
[171] M. Yeh,et al. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[172] A. Kidd,et al. Genetic variability in hepatitis B viruses. , 2002, The Journal of general virology.
[173] M. Strubin,et al. Hepatitis B virus X protein affects S phase progression leading to chromosome segregation defects by binding to damaged DNA binding protein 1 , 2008, Hepatology.
[174] Ji Hyun Jung,et al. Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. , 2003, Human molecular genetics.
[175] J. Barrett,et al. cis-Activation of the human telomerase gene (hTERT) by the hepatitis B virus genome. , 2001, Journal of the National Cancer Institute.
[176] Chien-Jen Chen,et al. Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma , 2008, Journal of the National Cancer Institute.
[177] Jun Qin,et al. Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. , 2005, Molecular cell.
[178] Mohamed Hassan,et al. Induction of high-molecular-weight (HMW) tumor necrosis factor(TNF) alpha by hepatitis C virus (HCV) non-structural protein 3 (NS3) in liver cells is AP-1 and NF-kappaB-dependent activation. , 2007, Cellular signalling.
[179] Seok-Geun Lee,et al. Transcriptional repression of the human p53 gene by hepatitis B viral X protein , 2000, Oncogene.
[180] Y. Berdichevsky,et al. Cell transformation induced by hepatitis C virus NS3 serine protease , 2001, Journal of viral hepatitis.
[181] L. Boscá,et al. Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins , 2004, Gut.
[182] G. Fattovich. Natural History and Prognosis of Hepatitis B , 2003, Seminars in liver disease.
[183] J. Wands,et al. Overexpression of insulin receptor substrate‐1 and hepatitis Bx genes causes premalignant alterations in the liver , 2009, Hepatology.
[184] J. Sheu,et al. Chromosomal abnormality in hepatocellular carcinoma by comparative genomic hybridisation in Taiwan. , 1999, European journal of cancer.
[185] K. Koike,et al. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. , 2001, Cancer research.
[186] P. Hofschneider,et al. The PreS2 activator MHBst of hepatitis B virus activates c‐raf‐1/Erk2 signaling in transgenic mice , 2002, The EMBO journal.
[187] Francis Simon,et al. Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3. , 2002, Biochimica et biophysica acta.
[188] Lifen Gao,et al. In vitro transfection of the hepatitis B virus PreS2 gene into the human hepatocarcinoma cell line HepG2 induces upregulation of human telomerase reverse transcriptase. , 2007, Biochemical and biophysical research communications.
[189] Jian-Min Yuan,et al. Prediagnostic level of serum retinol in relation to reduced risk of hepatocellular carcinoma. , 2006, Journal of the National Cancer Institute.
[190] M. Baptista,et al. High prevalence of 1762T 1764A mutations in the basic core promoter of hepatitis B virus isolated from black africans with hepatocellular carcinoma compared with asymptomatic carriers , 1999, Hepatology.
[191] S. Locarnini,et al. The hepatitis B virus and common mutants. , 2003, Seminars in liver disease.
[192] H. Nakamura,et al. Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection. , 2000, Journal of hepatology.
[193] J. Ou,et al. Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[194] I. B. Borel Rinkes,et al. Mouse models in liver cancer research: a review of current literature. , 2008, World journal of gastroenterology.
[195] Mu-jun Zhao,et al. Hepatitis B virus X protein sensitizes cells to starvation‐induced autophagy via up‐regulation of beclin 1 expression , 2009, Hepatology.
[196] J. Schaack,et al. Induced oxidative stress and activated expression of manganese superoxide dismutase during hepatitis C virus replication: role of JNK, p38 MAPK and AP-1. , 2004, The Biochemical journal.
[197] Hung-Yi Wu,et al. Hepatitis C Virus NS5A Protein Down-regulates the Expression of Spindle Gene Aspm through PKR-p38 Signaling Pathway* , 2008, Journal of Biological Chemistry.
[198] T. Roskams. Different types of liver progenitor cells and their niches. , 2006, Journal of hepatology.
[199] V. Wong,et al. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma , 2004, Gut.
[200] Chi-Hung Lin,et al. Hepatitis C Virus Core Protein Interacts with Cellular Putative RNA Helicase , 1999, Journal of Virology.
[201] Frank Scholle,et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. , 2002, Gastroenterology.
[202] Rajagopal N. Aravalli,et al. Molecular mechanisms of hepatocellular carcinoma , 2008, Hepatology.
[203] E. Lara-Pezzi,et al. The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells , 2008, Hepatology.
[204] Sheng-Nan Lu,et al. Aflatoxin exposure and hepatitis C virus in advanced liver disease in a hepatitis C virus endemic area in Taiwan. , 2007, The American journal of tropical medicine and hygiene.
[205] M. Honda,et al. Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. , 2002, Gastroenterology.
[206] Katsunori Yoshida,et al. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor β signaling, promoting cirrhosis and hepatocellular carcinoma , 2007, Hepatology.
[207] Ali Azizi,et al. Characterization of liver histopathology in a transgenic mouse model expressing genotype 1a hepatitis C virus core and envelope proteins 1 and 2. , 2005, The Journal of general virology.
[208] C. Bréchot,et al. Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis , 2006, Oncogene.
[209] M. Katze,et al. Subversion of Cell Signaling Pathways by Hepatitis C Virus Nonstructural 5A Protein via Interaction with Grb2 and P85 Phosphatidylinositol 3-Kinase , 2002, Journal of Virology.
[210] A. Siddiqui,et al. Hepatitis B Virus X Protein Stimulates the Mitochondrial Translocation of Raf-1 via Oxidative Stress , 2007, Journal of Virology.
[211] E. Peles,et al. Protein tyrosine kinase PYK2 involved in Ca2+-induced regulation of ion channel and MAP kinase functions , 1995, Nature.
[212] S. Porru,et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. , 2002, American journal of epidemiology.
[213] J. Bartolomé,et al. Hepatitis C virus core protein transactivates the inducible nitric oxide synthase promoter via NF-kappaB activation. , 2003, Antiviral research.
[214] V. Desmet,et al. Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. , 2001, Hepatology.
[215] P. Paterlini-Bréchot,et al. Cytobiological consequences of calcium-signaling alterations induced by human viral proteins. , 2006, Biochimica et biophysica acta.
[216] P. Tangkijvanich,et al. Association of HLA‐DRB1*13 and TNF‐α gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population , 2007, Journal of viral hepatitis.
[217] B. McMahon,et al. Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F. , 2007, The Journal of infectious diseases.
[218] V. Wong,et al. High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[219] Y. Takei,et al. Iron, hepatitis C virus, and hepatocellular carcinoma: iron reduction preaches the gospel for chronic hepatitis C , 2007, Journal of Gastroenterology.
[220] S. Caldwell,et al. The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology , 2009, Journal of Gastroenterology.
[221] S. Douc-Rasy,et al. TP53 family members and human cancers , 2003, Human mutation.